HLA-DRB and -DQB1 polymorphism in the Macedonian population
A Hristova-Dimceva1, W Verduijn, R F Schipper
1Institute of Blood Transfusion, Skopje, Republic of Macedonia.
Tissue Antigens
|March 7, 2000
Summary
This study details human leukocyte antigen (HLA) gene polymorphism in Macedonians. Researchers identified frequent HLA-DRB1 and DQB1 alleles and common three-locus haplotypes, noting some unusual DR2-related findings in this population.
Area of Science:
- Immunogenetics
- Population Genetics
- Molecular Anthropology
Background:
- Human Leukocyte Antigen (HLA) genes are crucial for immune response and transplantation.
- Understanding HLA polymorphism in diverse populations is essential for medical and anthropological insights.
- Previous HLA studies in Macedonian populations are limited, necessitating detailed genetic characterization.
Purpose of the Study:
- To investigate the polymorphism of HLA-DRB1, DRB3/4/5, and DQB1 loci in a healthy Macedonian population.
- To identify common alleles and haplotypes within this specific ethnic group.
- To compare findings with other European populations and identify any unique genetic patterns.
Main Methods:
- Molecular methods were employed to analyze DNA from 80 unrelated healthy Macedonian individuals.
- High-resolution typing was performed for HLA-DRB1, DRB3/4/5, and DQB1 gene regions.
- Statistical analysis was used to determine allele and haplotype frequencies.
Main Results:
- Twenty-five distinct DRB1 alleles were identified, with DRB1*1104, *1501, *1601, and *1101 being the most prevalent.
- Fifteen DQB1 alleles were found, dominated by DQB1*0301 and *0502.
- The most frequent three-locus haplotypes were DRB1*1104-DRB3*02-DQB1*0301 (18%), DRB1*1101-DRB3*02-DQB1*0301 (9%), and DRB1*1601-DRB5*02-DQB1*0502 (10%).
- Extensive polymorphism was observed for DRB1*04, *13, and *15 haplotypes, including eleven DR2-related haplotypes, some uncommon in Europeans.
Conclusions:
- The study provides a comprehensive profile of HLA-DRB1, DRB3/4/5, and DQB1 genetic variation in Macedonians.
- Identified allele and haplotype frequencies contribute valuable data for anthropological and clinical applications in the region.
- The presence of unusual DR2-related haplotypes suggests unique evolutionary or historical influences on the Macedonian gene pool.
Related Concept Videos
Genetic Lingo
Overview
Multiple Allele Traits
The Concept of Multiple Allelism
Blood Types
Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...


